Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Gyrolab CHO-HCP Kit 1 detects and quantifies host cell proteins from Chinese hamster ovary cells.

Kit Detects and Quantifies HCPs

The draft guidance document clarifies chemistry, manufacturing, and controls information for marketing applications.

FDA Releases Guidance on CMC Changes for Biologics

Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.

Innovative Inhaled Antipsychotic Formulation Adasuve Provides Quick and Effective Treatment

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Widespread use and abuse of opioid painkillers is prompting efforts to develop new drugs and formulations that resist abuse while providing relief to legitimate patients.

Generic Opioids Create Policy Issues

Eight physician groups wrote to the commissioner of FDA to stress the importance of transparency in biosimilar labeling to decrease prescribing risks.

Physician Groups Band Together on Labeling of Biosimilars

Appropriate feeding equipment can be selected to meet the challenges of dosing powders that are sticky or do not flow well.

Handling Difficult Powders in Solid-Dosage Manufacturing

As the biopharma industry awaits FDA’s guidance on biosimilar naming, brand and generic manufacturers establish positions.

Fight Over Biosimilar Naming Continues

OXY-CAPT brings together properties of plastic and glass containers through the combination of oxygen absorption and cyclic olefin copolymer (COP) high barrier layers.

Mitsubishi Introduces New Plastic Syringe and Vial for Parenteral Pharmaceuticals

Medicago's new production facility will make plant-based vaccines and therapeutics.

Medicago Plans Vaccine Facility In Quebec City

CVS Health signed a definitive agreement to acquire Omnicare for $12.7 billion to expand its reach to assisted living and long-term care facilities.